Institutional investors hold a majority ownership of AMGN through the 82.37% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 1.9 Million shares of Amgen
WINSLOW CAPITAL MANAGEMENT LLC Bought 1.4 Million shares of Amgen
ARISTOTLE CAPITAL MANAGEMENT LLC Bought 1.3 Million shares of Amgen